T1D in Film: Why Does Representation Matter?
If you’ve spent any time on social media recently, you’ve likely heard the buzz around the latest Pixar film, Turning…
Get Up Close and in the Know with Sean Salmon, President of Medtronic Diabetes
T1D Exchange recently had the opportunity to interview Sean Salmon, President of Medtronic Diabetes. In this interview, we discuss Medtronic’s…
Vertex Q&A: Promising New Data & Future of Cell Therapies
Vertex Pharmaceuticals, a global biotech company and forerunner in stem cell-derived therapies for people living with type 1 diabetes (T1D),…
An Interview with Dr. Enrique Caballero: Providing Culturally-Oriented Care to the Latinx Community
Meet Dr. A. Enrique Caballero: a Boston-based endocrinologist with decades of experience providing diabetes care to the Latinx community. After…
Connect1d Canada partners with the T1D Exchange
Connect1d Canada, a digital platform that allows those with type 1 diabetes (T1D) to easily learn about and participate in…
T1D Exchange Appoints Two New Members to its Board of Directors
T1D Exchange announced today the appointments of Dr. Margarita Ochoa-Maya and Dr. Kevin Larsen to its Board of Directors. Their…
A Parent’s Guide for Back-to-School with T1D
Life with diabetes can bring a lot of stress, but one of the most stressful events for parents and children…
Latest News on CGM and Dexcom Straight from the CEO, Kevin Sayer
T1D Exchange recently took advantage of the golden opportunity to interview Kevin Sayer, chairman, president and CEO of Dexcom. In…
The Latest from Viacyte, Dexcom and More at ADA
Scientific Sessions, or “Sci Sessions” for short, is the world’s largest meeting of the best and brightest researchers, health care…
T1D Exchange Research in the Spotlight at ADA
From June 25-29, 2021, the most brilliant minds in diabetes research gathered (virtually) for the American Diabetes Association’s (ADA) 81st…
